Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.

Adjuvant Lynparza remains beneficial for patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, study results have shown.

I haven’t been too happy with my blood work with CLL, but I try to enjoy what I can — including apples during fall.

Among patients with ER-positive/HER2-negative advanced breast cancer, treatment with camizestrant in combination with Kisqali ...

Jaypirca showed superior progression-free survival and lower discontinuation rates versus standard treatments in patients ...